Viewing nowCombinationDuoGly Tablet
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.

MFDS item code 202200497 · Approved 2022.01.28 · Insurance code 669908260
Improvement of blood sugar control in type 2 diabetes
This medication is used to complement diet and exercise regimens to improve blood sugar control in patients with type 2 diabetes. It is particularly effective for patients suitable for combination therapy with sitagliptin and dapagliflozin. It helps maintain a healthy lifestyle by managing blood sugar levels more stably.
This medication can be taken by patients receiving 100 mg of sitagliptin and 10 mg of dapagliflozin, at a dose of 1 tablet once daily, regardless of meals. The tablet should be swallowed whole.
This medication may cause hypersensitivity reactions, so if any allergic symptoms or skin conditions occur within the first 3 months, usage should be discontinued immediately. Acute pancreatitis may occur; if abdominal pain or symptoms of pancreatitis such as vomiting appear, consult a doctor immediately. Patients with hypersensitivity to any of the active ingredients or additives, as well as those with type 1 diabetes, diabetic ketoacidosis, certain genetic lactase deficiency disorders, and those undergoing dialysis, should not use this medication. Patients with renal impairment or elderly patients at risk of decreased fluid volume, as well as those on diuretics, should assess renal function and fluid status before taking this medication and should monitor periodically during treatment. Side effects such as genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, headache, dry mouth, and constipation may occur while taking this medication, so if any symptoms arise, inform healthcare professionals and receive appropriate treatment. Especially since this medication has a blood sugar-lowering effect, the risk of hypoglycemia increases when taken with other hypoglycemic agents such as insulin or sulfonylureas, thus dosage adjustment may be necessary. Women who are pregnant or breastfeeding should avoid using this medication and discontinue its use immediately upon confirmation of pregnancy. For children under 18 years of age, the safety and efficacy of this medication have not been established, so it should not be used. In case of overdose, there is no specific antidote; visit a healthcare facility immediately for treatment according to symptoms, and dialysis may be considered if needed. This medication does not significantly affect driving or machinery operation, but caution is advised due to the possibility of hypoglycemic symptoms.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hemorrhagic or necrotizing pancreatitis, severe skin adverse reactions, severe and disabling arthralgia, blistering similar to pemphigus, worsening renal function, acute renal failure, neurological abnormalities (severe headache, lightning headache, seizures, confusion, vision changes, paralysis), perineum
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain storage temperature between 1 and 30 degrees Celsius. Avoid storing in excessively hot or cold places.
Yellow rectangular film-coated tablet
28 tablets/box [7 tablets/PTP × 4], 30 tablets/box [10 tablets/PTP × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.